SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031621
Filing Date
2023-11-13
Accepted
2023-11-13 16:15:46
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20230930_10q.htm   iXBRL 10-Q 1046399
2 EXHIBIT 31.1 ex_563737.htm EX-31.1 12831
3 EXHIBIT 31.2 ex_563738.htm EX-31.2 12809
4 EXHIBIT 32.1 ex_563739.htm EX-32.1 4909
5 EXHIBIT 32.2 ex_563740.htm EX-32.2 4877
  Complete submission text file 0001437749-23-031621.txt   4928771

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230930.xsd EX-101.SCH 50149
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20230930_cal.xml EX-101.CAL 23414
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20230930_def.xml EX-101.DEF 319524
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230930_lab.xml EX-101.LAB 305784
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230930_pre.xml EX-101.PRE 340167
46 EXTRACTED XBRL INSTANCE DOCUMENT atxi20230930_10q_htm.xml XML 714861
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 231398953
SIC: 2834 Pharmaceutical Preparations